Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-99-007716
Filing Date
1999-08-16
Accepted
1999-08-16 00:00:00
Documents
9
Period of Report
1999-06-30

Document Format Files

Seq Description Document Type Size
1 OSI PHARMACEUTICALS, INC. 10-Q 76252
2 ASSET PURCHASE AGREEMENT EX-2.1 88965
3 NON-QUALIFIED STOCK OPTION PLAN EX-2.2 20589
4 COLLABORATIVE RESEARCH AGREEMENT EX-10.1 98128
5 AMENDED & RESTATED STOCKHOLDERS' AGREEMENT EX-10.2 74185
6 DEVELOPMENT AGREEMENT EX-10.3 43398
7 AMENDMENT NO. 1 EX-10.4 1272
8 AMENDMENT NO. 2 EX-10.5 39670
9 FINANCIAL DATA SCHEDULE EX-27 2247
  Complete submission text file 0000950123-99-007716.txt   447069
Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-15190 | Film No.: 99691329
SIC: 2835 In Vitro & In Vivo Diagnostic Substances